NGS for (Hemato-) Oncology in Belgium: Evaluation of Laboratory Performance and Feasibility of a National External Quality Assessment Program
Next-generation sequencing (NGS) is being integrated into routine clinical practice in the field of (hemato-) oncology to search for variants with diagnostic, prognostic, or therapeutic value at potentially low allelic frequencies. The complex sequencing workflows used require careful validation and...
Main Authors: | Thomas Delcourt, Kevin Vanneste, Mohamed Rida Soumali, Wim Coucke, Vanessa Ghislain, Aline Hebrant, Els Van Valckenborgh, Sigrid C. J. De Keersmaecker, Nancy H. Roosens, Philippe Van De Walle, Marc Van Den Bulcke, Aline Antoniou |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-10-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/12/11/3180 |
Similar Items
-
Analysis of Vancomycin-Resistant Enterococci in Hemato-Oncological Patients
by: Kristýna Hricová, et al.
Published: (2020-11-01) -
Orofacial manifestation of hematological disorders: Hemato-oncologic and immuno-deficiency disorders
by: Titilope A Adeyemo, et al.
Published: (2011-01-01) -
Association of systolic blood pressure drop with intravenous administration of itraconazole in children with hemato-oncologic disease
by: Lee HJ, et al.
Published: (2015-12-01) -
Progress in pediatrics in 2011. Choices in endocrinology, gastroenterology, hemato-oncology, infectious diseases, otolaryngology, pharmacotherapy and respiratory tract illnesses
by: Caffarelli Carlo, et al.
Published: (2012-06-01) -
Roadbook for the implementation of next-generation sequencing in clinical practice in oncology and hemato-oncology in Belgium
by: Els Van Valckenborgh, et al.
Published: (2018-09-01)